1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
653D08A15905E3C4D85256C9300719884
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-winning-trademarks-development-strategies?opendocument
18
19opendocument
2034.204.176.71
21
22
23
24/bestp/domrep.nsf
25DB




» Products & Services » » Brand Management and Product Leadership » Branding and Identity

Winning Trademark Development Strategies

DB Image

ID: 4391


Features:

Metrics, Graphics, Summary Matrix


Pages/Slides: 29


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This document contains tactics to help pharmaceutical companies uncover successful strategies for trademark development. This benchmarking research includes insights and lessons learned from six leading pharmaceutical companies on the following key topics: success drivers, global trademark options, brand protection tactics, modifier strategies, and multiple trademark issues.

Industries Profiled:
Pharmaceutical; Health Care; Medical Device


Companies Profiled:
AstraZeneca; Sanofi-aventis; Eli Lilly; GlaxoSmithKline; Johnson & Johnson; Merck

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.